Kazutoshi Isobe

Sakura, 2858741, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 29, 2026

Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review.

Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review.

Journal: Cureus

Published: December 08, 2025

Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study.

Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study.

Journal: BMC pulmonary medicine

Published: November 29, 2025

Successful Bronchial Occlusion With an Endobronchial Watanabe Spigot Using a Single-Use Bronchoscope for Bronchobiliary Fistula: A Case Report.

Successful Bronchial Occlusion With an Endobronchial Watanabe Spigot Using a Single-Use Bronchoscope for Bronchobiliary Fistula: A Case Report.

Journal: Respirology case reports

Published: August 31, 2025

Differentiating respiratory syncytial virus pneumonia from interstitial lung disease associated with systemic sclerosis: A case report.

Differentiating respiratory syncytial virus pneumonia from interstitial lung disease associated with systemic sclerosis: A case report.

Journal: Medicine

Published: August 01, 2025

Antiphospholipid Syndrome Mimicking Acute Exacerbation of Interstitial Pneumonia: A Case Report and Literature Review.

Antiphospholipid Syndrome Mimicking Acute Exacerbation of Interstitial Pneumonia: A Case Report and Literature Review.

Journal: Respirology case reports

Published: June 18, 2025

Efficacy and Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer and Autoimmune Diseases.

Efficacy and Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer and Autoimmune Diseases.

Journal: Cureus

Published: May 29, 2025

A Case of Stevens-Johnson Syndrome Triggered by Methicillin-Resistant Staphylococcus aureus Infection During Pembrolizumab Treatment for Lung Squamous Cell Carcinoma.

A Case of Stevens-Johnson Syndrome Triggered by Methicillin-Resistant Staphylococcus aureus Infection During Pembrolizumab Treatment for Lung Squamous Cell Carcinoma.

Journal: Respirology case reports

Published: May 01, 2025

Extended 73-month survival in an elderly patient with BRAF V600E-mutated lung adenocarcinoma: A case report.

Extended 73-month survival in an elderly patient with BRAF V600E-mutated lung adenocarcinoma: A case report.

Journal: Respirology case reports

Published: September 14, 2024

Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.

Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.

Journal: BMC pulmonary medicine

Published: April 02, 2024

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 30, 2024

A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.

A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.

Journal: ESMO open

Published: March 25, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026